Elevated HIF consequent to VHL loss upregulates TGF-α, an EGFR ligand, in ccRCC tumors and cell lines while reintroduction of wild type pVHL attenuates TGF-α expression in ccRCC cells [78,79]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.